By mid-decade, a substantial portion of GLP-1 APIs especially generics may come from CDMOs
The FDA also recommends examining hard clinical endpoints such hepatic decompensations, transplant free survival, and all-cause mortality, although these results are not necessarily needed prior to drug approval given the long length of follow up potentially required
Satiety fills the stomach
The progress on The Metabolic Coach has been rapid, and we are once again validated by the latest clinical publications regarding the CMS BALANCE Model
These two actions result in a decreased FFA flux in the liver, improving insulin and IGF-1 signalling
Glucagon-like peptide 2 (GLP-2) peptide molecule teduglutide The bioanalytical assay developed by BioPharma Services utilizes a combination of protein precipitation and solid phase extraction procedure using a Phenomenex SPE 96 well plate